Research programme: acne vaccine - UC San Diego/sanofi pasteur

Drug Profile

Research programme: acne vaccine - UC San Diego/sanofi pasteur

Alternative Names: Acne vaccine - sanofi pasteur; Acne vaccine - University of California in San Diego/sanofi pasteur

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of California, San Diego
  • Developer Sanofi Pasteur; University of California, San Diego
  • Class Vaccines
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Acne

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Acne in USA
  • 21 Sep 2011 University of California, San Diego's acne vaccine licensed to sanofi pasteur worldwide for the treatment/prevention of Acne
  • 21 Sep 2011 Preclinical trials in Acne in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top